Inhibition of glycosylation on a camelid antibody uniquely affects its FcγRI binding activity-Reference-Cited by-同舟云学术

Inhibition of glycosylation on a camelid antibody uniquely affects its FcγRI binding activity

Published:2017-01 Issue: Volume:96 Page:428-439
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Krahn Natalie,Spearman Maureen,Meier Markus,Dorion-Thibaudeau July,McDougall Matthew,Patel Trushar R.,De Crescenzo Gregory,Durocher Yves,Stetefeld Jörg,Butler Michael

Funder

NSERC

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference71 articles.

1. Impact of glycosylation on effector functions of therapeutic IgG;Abès;Pharmaceuticals,2010

2. Panitumumab: a new frontier of target therapy for the treatment of metastatic colorectal cancer;Addeo;Expert. Rev. Anticancer. Ther.,2010

3. Stable expression of chimeric heavy chain antibodies in CHO cells;Agrawal;Methods Mol. Biol.,2012

4. NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic;Barb;Nat. Chem. Biol.,2011

5. NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation;Barb;Biochemistry,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating antibody effector functions by Fc glycoengineering;Biotechnology Advances;2023-10

2. Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects;Frontiers in Plant Science;2022-04-29

3. Structural Characterization of RC28-E, a Recombinant Fusion Protein With Dual Targets on VEGF and FGF2;Natural Product Communications;2022-03

4. Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors;Antibodies;2021-11-04

5. Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality Assurance;Cell Engineering;2021